PROT# PX-171-007: Phase 1b/2, Multicenter Open-Label Study of the Safety and Activity of Carfilzomib in Subjects with Relapsed Solid Tumors and in Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date6/17/10 → 6/17/17

Funding

  • Onyx Pharmaceuticals, Inc. (PX-171-007)